10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG)

Historical Holders from Q3 2019 to Q3 2025

Symbol
TXG on Nasdaq
CUSIP
88025U109
Type / Class
Equity / Class A common stock, par value $0.00001 per share
Shares outstanding
114M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
123M
Holdings value
$1.44B
% of all portfolios
0.002%
Grand Portfolio weight change
+0%
Number of holders
298
Number of buys
157
Number of sells
-130
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 11.6% $155M 13.3M The Vanguard Group Sep 30, 2025
ARK Investment Management LLC 10.39% -12.3% $139M -$11.2M 11.9M -7.46% ARK Investment Management LLC Sep 30, 2025
FMR LLC 8.1% -22% $109M -$26.3M 9.28M -19.5% FMR LLC Sep 30, 2025
BlackRock, Inc. 7.6% $80.6M 8.5M BlackRock, Inc. Jun 30, 2025
Sumitomo Mitsui Trust Group, Inc. 4.7% -14% $62.9M -$7.4M 5.38M -10.5% Sumitomo Mitsui Trust Group, Inc. Sep 30, 2025
Amova Asset Management Americas, Inc. 4.7% -14% $62.9M -$7.4M 5.38M -10.5% Amova Asset Management Americas, Inc. Sep 30, 2025
MILLENNIUM MANAGEMENT LLC 2.7% -48% $35.4M -$28.6M 3.06M -44.7% Millennium Management LLC Jun 30, 2025

Institutional Holders of 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 123M $1.44B +$6.58M $11.69 298
2025 Q2 123M $1.42B +$120M $11.58 292
2025 Q1 114M $993M +$50.9M $8.73 268
2024 Q4 104M $1.5B -$41.5M $14.36 270
2024 Q3 104M $2.35B -$4.31M $22.58 257
2024 Q2 105M $2.05B +$26.4M $19.45 253
2024 Q1 102M $3.83B +$143M $37.53 279
2023 Q4 117K $6.53M -$825K $55.96 4
2023 Q3 89.5M $3.69B +$73.6M $41.25 249
2023 Q2 82.8M $4.63B +$183M $55.84 263
2023 Q1 90.1M $5.02B +$210M $55.79 252
2022 Q4 86.2M $3.14B +$102M $36.44 247
2022 Q3 85.2M $2.43B -$45.9M $28.48 198
2022 Q2 85.9M $3.9B +$76.6M $45.25 221
2022 Q1 81.7M $6.21B -$97.6M $76.07 278
2021 Q4 77.9M $11.6B -$1.59M $148.96 335
2021 Q3 78.8M $11.5B +$123M $145.58 315
2021 Q2 77.5M $15.2B +$1.48B $195.82 331
2021 Q1 68.8M $12.5B +$737M $181.00 309
2020 Q4 66.2M $9.38B -$748M $141.60 293
2020 Q3 68.9M $8.52B +$1.08B $124.68 214
2020 Q2 60.8M $5.43B +$1.15B $89.31 138
2020 Q1 38.9M $2.42B +$608M $62.32 99
2019 Q4 30.8M $2.35B +$109M $76.25 84
2019 Q3 22.3M $1.13B +$1.13B $50.40 92